Imagion Biosystems and Siemens Healthineers Extend Collaboration
Imagion Biosystems has extended its collaboration with Siemens Healthineers to support the Phase 2 clinical trial of the MagSense imaging agent for HER2-positive breast cancer.
mammography CT